Sekimata M，Yoshida D, Araki A, Asao H, Iseki K and Murakami-Sekimata A，Runx1 and RORγt Cooperate to Upregulate IL-22 Expression in Th Cells through Its Distal Enhancer，J Immunol, ,202: 3198-3210. 2019
Suina Y, Homma C, Aso Y, Yagihashi S，Sekimata M，Sekimata A，The effects of serum replacement and Rho-associated protein kinase (ROCK) inhibitor, Y-27632 on the monolayer-culture of mouse embryonic submandibular gland epithelial cells in serum-free medium，Yamagata Med J, 36(2): 98-105. 2018
Nakao A, Inaba T, Murakami-Sekimata A., Nogawa H, Morphogenesis and Mucus Production of Epithelial Tissues of Three Major Salivary Glands of Embryonic Mouse in 3D Culture ，Zoolog Sci, 34(6): 475-483. 2017
Hayasaka Y，Nogawa H，Sekimata M，Murakami-Sekimata A，The effects of neurogulin 1 and/or fibroblast growth factor 1 on the differentiation of mouse embryonic submandibular glan ex vivo culture cells，Yamagata Med J, 34(2): 42-49. 2016
Sekimata M., Murakami-Sekimata A., Homma Y., “CpG methylation prevents YY1-mediated transcriptional activation of the vimentin promoter.” Biochem Biophys Res Commun. 414(4): 767-772. 2011
Murakami-Sekimata A., Huang D., Piening B.D., Bangur C., Paulovich A.G., “The Saccharomyces cerevisiaeRAD9, RAD17 and RAD24 genes are required for suppression of mutagenic post-replicative repair during chronic DNA damage”, DNA repair 9(7): 824-834. 2010
Murakami-Sekimata A., Sato K., Sato K., Takashima A., Nakano A., “O-Mannosylation is required for the solbilization of heterologously expressed human beta-amyloid precursor protein in Saccharomyces cerevisiae.” Genes Cells. 14(2): 205-215. 2009
Sekimata M., Takahashi A., Murakami-Sekimata A., and Homma Y., “Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG binding protein, MBD2.” J. Biol. Chem. 276(46): 42632-42638. 2001.
Murakami A., Kimura K., and Nakano A., “The inactive form of a yeast casein kinase I suppressed the secretory defect of the sec12 mutant.” J. Biol. Chem. 274(6): 3804-3810. 1999.
Murakami A., Chida K., Suzuki Y., Kikuchi H., Imajoh-Ohmi S., and Kuroki T., “Absence of down-regulation and translocation of the eta-isoform of protein kinase C in Normal human keratinocytes.” J. Invest. Dermatol. 106: 790-794. 1996.
Chida K., Murakami A.., Tagawa T., Ikuta T., and Kuroki T., “Cholesterol sulfate, a second messenger for the eta-isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.” Canser Res. 55: 4865-4869. 1995.
Chida K., Sagara H., Suzuki Y., Murakami A.., Osada S., Ohno S., Hirosawa K., and Kuroki T., “The eta-isoform of protein kinase C is localized on rough endoplasmic reticulum.” Mol. Cell Biol. 14: 3782-3790. 1994.
Murakami-Sekimata A.., Lee J., Mandoli DF., “understanding mechanisms of mRNA localization in plants using carbonic anhydrase (CA) in Acetabularia acetabulum as a model system”, FASEB meeting , Tucson, USA (2005)
Murakami-Sekimata A., Lee J., Mandoli DF., “understanding mechanisms of mRNA localization in plants using carbonic anhydrase (CA) in Acetabularia acetabulum as a model system”, American Society of Plant Biologists, Seattle, USA (2005)
Murakami A., Kimura K., and Nakano A., “A mutation of a yeast casein kinase I gene, RST2/HRR25, suppresses the vesicular transport defect of sec12.” 3rd The Asian-Pacific organization for Cell biology (3rd APOCB congress) in Osaka, Japan. (1998)
Murakami A., Kimura K., and Nakano A. “A mutation of a yeast casein kinase I gene, RST2/HRR25, suppresses the vesicular transport defect of sec12.” 38th American Society for Cell Biology Annual Meeting, San Francisco, USA (1998)
